3Q12 US Copaxone sales were $775M, +3% YOY and +11% QoQ: http://finance.yahoo.com/news/teva-reports-third-quarter-2012-110000915.html US Copaxone sales for the first 9 months of 2012 were $2.09B, ahead of the pace to meet my estimate of $2.6B for the full year (#msg-75932085).